Emicizumab dose capping in obese patients with Haemophilia A: Early outcomes at a single centre

Haemophilia. 2022 Nov;28(6):e245-e247. doi: 10.1111/hae.14644. Epub 2022 Aug 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Factor VIII
  • Hemophilia A* / complications
  • Hemophilia A* / drug therapy
  • Humans
  • Obesity / complications
  • Obesity / drug therapy

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • Factor VIII